GSK
803 hedge funds and large institutions have $11.2B invested in GSK in 2019 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 289 increasing their positions, 287 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $11.7B → $11.2B (-$557M)
5% less funds holding
Funds holding: 846 → 803 (-43)
35% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 92
Holders
803
Holding in Top 10
14
Calls
$98M
Puts
$74.7M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$39.6M | |
| 3 | +$34.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$31.9M |
Top Sellers
| 1 | -$190M | |
| 2 | -$68.2M | |
| 3 | -$28.8M | |
| 4 |
Millennium Management
New York
|
-$28.1M |
| 5 |
MAM
Majedie Asset Management
London,
United Kingdom
|
-$18M |